Optical Coherence Tomography OCT For Healthcare And Life Science Market Projected To Experience Growth With CAGR 16.1%

November 26, 2024 12:30 AM AEDT | By EIN Presswire
 Optical Coherence Tomography OCT For Healthcare And Life Science Market Projected To Experience Growth With CAGR 16.1%
Image source: EIN Presswire

LONDON, GREATER LONDON, UNITED KINGDOM, November 25, 2024 /EINPresswire.com/ -- The Business Research Company’s Early Year-End Sale! Get up to 30% off detailed market research reports—limited time only!

What Are The Predicted Growth Figures For The Optical Coherence Tomography OCT For Healthcare And Life Science Market Over The Coming Years?

The optical coherence tomography OCT for healthcare and life science market, touted for its rapid expansion in recent years, is predicted to grow from $1.69 billion in 2023 to $1.96 billion in 2024, reflecting a compound annual growth rate CAGR of 16%. This significant growth during the historic period can be attributed to the increasing prevalence of eye diseases, growing aging population, rise in government healthcare initiatives, expansion of healthcare infrastructure, increasing adoption of non-invasive diagnostic tools, and the escalation in research and development in medical imaging.

The future also bodes well for the OCT market, with predictions of sustained growth in the next few years. By 2028, the market size is expected to reach $3.57 billion, with a compound annual growth rate CAGR of 16.1%. This growth during the forecast period is anticipated due to increasing demand for early diagnosis and treatment, a rise in chronic diseases requiring OCT, a growing geriatric population, an uptick in investments in medical imaging research, and a growing prevalence of retinal disorders.

Obtain a detailed sample report to gain a deeper understanding of this market: https://www.thebusinessresearchcompany.com/sample.aspx?id=19130&type=smp

What Are The Major Factors Driving The Optical Coherence Tomography For Healthcare And Life Science Market Growth?

A key player driving the growth of the OCT market is the rising incidence of ocular diseases. Ocular diseases affect the eyes and their surrounding structures and can lead to vision impairment or blindness. They are largely attributed to the aging population and the increased prevalence of chronic conditions such as diabetes. OCT is used to provide detailed, cross-sectional images of the retina and optic nerve, essential for diagnosing and monitoring ocular diseases.

For example, a report from Review of Optometry in December 2022 noted an estimated 80 million people globally are affected by glaucoma, with open-angle glaucoma OAG accounting for 95% of these cases. In the U.S. alone, more than three million individuals are currently living with the condition. Moreover, the figure is projected to exceed 111 million by 2040. This increasing incidence of ocular diseases globally will continue to fuel the growth of the OCT market.

Get access to the full report for in-depth insights: https://www.thebusinessresearchcompany.com/report/optical-coherence-tomography-oct-for-healthcare-and-life-science-global-market-report

How Is The Optical Coherence Tomography For Healthcare And Life Science Market Segmented?

The OCT for healthcare and life science market comprises various segments:

1. By Type: Catheter Based Optical Coherence Tomography OCT Devices, Doppler Optical Coherence Tomography OCT Devices, Handheld Optical Coherence Tomography OCT Devices, Tabletop Optical Coherence Tomography OCT Devices
2. By Technology: Time Domain Oct TdOct, Frequency Domain Oct FdOct, Other Technologies
3. By Application: Ophthalmology, Cariology, Dermatology, Gastroenterology, Other Applications
4. By End Users: Hospitals, Specialty Clinics, Research Institutes, Other End Users

What Are The Key Trends Shaping The Optical Coherence Tomography For Healthcare And Life Science Market?

Major companies operating in the OCT for healthcare and life science markets are emphasizing the integration of artificial intelligence platforms. The primary aim is to automate and improve the efficiency of OCT scan analysis, thus enhancing diagnostic accuracy and patient outcomes.

For instance, in October 2022, Altris Inc., a US-based medical technology company, launched Altris AI. This artificial intelligence platform is designed to automate OCT examination by providing fast analysis and visualization of 100 retinal pathologies. The cloud-based software allows for the automated screening, segmentation, and classification of OCT scans.

Browse More Related Reports:
Computed Tomography (CT) Scanners Devices And Equipment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/computed-tomography-ct-scanners-devices-and-equipment-global-market-report

Optical Coherence Tomography Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/optical-coherence-tomography-global-market-report

Single-Photon Emission Computed Tomography (SPECT) Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/single-photon-emission-computed-tomography-spect-global-market-report

About The Business Research Company
Learn More About The Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.


Contact us at: The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
X
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.